An Israeli airstrike in Syria kills a high-ranking Iranian general
Beirut (AP): An Israeli airstrike on Monday in a Damascus neighbourhood killed a high-ranking Iranian general, Iranian state media said.
The killing of Razi Mousavi, a long-time adviser of the Iranian paramilitary Revolutionary Guard in Syria, comes as clashes along the Lebanon-Israel border between Hezbollah and Israel continue to intensify with fears of the Israel-Hamas war sparking a regional spillover with Iran-backed groups. The Israeli strikes killed two other generals earlier this month in Syria.
Israel struck the Sayida Zeinab neighbourhood, located near a Shiite Muslim shrine, Iran's official news agency IRNA and Britain-based opposition war monitor the Syrian Observatory for Human Rights said. IRNA described Mousavi as a close companion of Gen. Qassim Soleimani, the head of Iran's elite Quds Force who was slain in a US drone strike in Iraq in January 2020.
Neither the Israeli military nor Syrian state media immediately issued a statement about the attack.
Though IRNA didn't provide other details about the attack, the Syrian Observatory for Human Rights said the Israeli military targeted Mousavi after he entered a farm in the area, which allegedly was one of several offices for Hezbollah. The Lebanese group, alongside Iran and Russia, has played a key military role in keeping President Bashar Assad's government in power throughout the Syrian conflict.
Israel has carried out hundreds of strikes on targets inside government-controlled parts of war-torn Syria in recent years.
It doesn't usually acknowledge its airstrikes on Syria. But when it does, it says it's targeting Iranian-backed groups there that have backed Assad's government.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
KMC Mangaluru team led by Dr. Haroon files patent for absorbent pads for elderly women
Aims to address urinary incontinence in elderly women
_vb_78.jpeg)
Mangaluru: Kasturba Medical College (KMC) has filed a patent application for “Absorbent Pads” designed to address urinary incontinence among elderly women, a condition that remains largely underreported despite its widespread impact.
Urinary incontinence does not command urgency like a heart attack, nor does it evoke the same collective response as more visible illnesses. However, for those living with it, the burden is constant, intimate, and often isolating.
There is a gradual and often unspoken impact on daily life. It begins with hesitation, declining invitations, avoiding travel, and choosing silence over conversation. Over time, this can lead to withdrawal, where fear of embarrassment starts shaping everyday decisions. For many elderly women, dignity becomes tied to small, often invisible compromises, including limiting outings or adjusting routines.
What makes this condition particularly poignant is not just its prevalence, but its invisibility. It is endured, not expressed. Accepted, not addressed.
It is in this context that the recent innovation assumes importance. The team at KMC, which includes clinicians such as Dr Haroon Hussain, has approached the issue not merely from a technical standpoint but from the perspective of lived experience.
The proposed solution, biodegradable, antimicrobial absorbent pads with improved fluid control and reduced irritation, aims to go beyond basic functionality, addressing comfort, safety, and dignity.
The development also reflects the role of academic institutions in addressing everyday health challenges. When research focuses not only on major diseases but also on conditions that affect quality of life, it reinforces the broader purpose of healthcare.
However, experts note that innovation alone cannot fully address the issue. Urinary incontinence continues to be underreported, often dismissed as an inevitable consequence of ageing. Many women do not seek medical help, not due to a lack of solutions, but because of stigma and discomfort associated with discussing the condition.
This creates a paradox, a widespread issue that is often experienced in isolation.
Medical professionals emphasise that greater awareness and open conversations are essential. Families must learn to speak about such issues without embarrassment. Healthcare providers must create spaces where patients feel heard without judgment.
The significance of this innovation lies not only in its technical aspects but also in what it brings into focus, that even the most private discomforts deserve public attention.
The patent application was filed by a team comprising Dr. Haroon Hussain, Dr. Sameena, Dr. Ritu Raval of Manipal Institute of Technology, Syed Ayaan Hussain Rizvi, and Suzanne Riya Dsouza.
_vb_49.jpeg)
_vb_90.jpeg)